embecta to Participate at the J.P. Morgan 2026 Healthcare Conference
Rhea-AI Summary
Embecta (Nasdaq: EMBC) said management will present at the J.P. Morgan 2026 Healthcare Conference in San Francisco on Wednesday, January 14, 2026 at 2:15 p.m. PT / 5:15 p.m. ET. Audio webcasts of the presentations will be available in the News & Events section of the company's investor relations website at investors.embecta.com.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
EMBC showed a modest pre-news decline of -0.93% while peers were mixed: PLSE up 0.28%, BLFS up 0.72%, STAA down -8.22%, ANGO down -0.15%, KMTS flat. This points to stock-specific, not broad sector, dynamics.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 25 | Earnings & guidance | Neutral | -7.2% | FY2025 results and FY2026 guidance with revenue declines versus prior year. |
| Nov 25 | Dividend declaration | Positive | -7.2% | Quarterly cash dividend of $0.15 per share announced. |
| Nov 17 | Board changes | Neutral | -0.7% | Director resignation and planned leadership transitions on the board. |
| Nov 14 | Humanitarian initiative | Positive | +1.0% | Expanded Direct Relief partnership and donations of diabetes injection devices. |
| Nov 11 | Earnings date set | Neutral | +2.0% | Announcement of timing for FY2025 results and guidance call. |
Recent earnings and dividend news coincided with notable share price declines, while operational or philanthropic updates tended to see modest positive or muted reactions.
Over the last few months, embecta reported FY2025 results on Nov 25, 2025, with revenues of $1,080.4M (down 3.8% YoY) and preliminary FY2026 guidance, which coincided with a -7.24% move. The same day it declared a quarterly dividend of $0.15 per share, also followed by a -7.24% reaction. Board changes on Nov 17, 2025 saw only a -0.7% move, while a major humanitarian diabetes initiative on Nov 14, 2025 and an earnings-date announcement on Nov 11, 2025 were met with modest gains.
Market Pulse Summary
This announcement highlights embecta’s plan to present at the J.P. Morgan Healthcare Conference on January 14, 2026, offering management a platform to engage with investors. In the months leading up to this, the company reported FY2025 results, issued FY2026 guidance, and declared a $0.15 quarterly dividend. Investors may focus on how any conference commentary builds on those financial disclosures and prior strategic and governance updates.
AI-generated analysis. Not financial advice.
PARSIPPANY, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026 at 2:15 p.m. PT / 5:15 p.m. ET.
Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at investors.embecta.com.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
Contacts:
| Media Christian Glazar Sr. Director, Corporate Communications 908-821-6922 Contact Media Relations | Investors Pravesh Khandelwal VP, Head of Investor Relations 551-264-6547 Contact IR |
FAQ
When will Embecta (EMBC) present at the J.P. Morgan 2026 Healthcare Conference?
How can investors listen to the Embecta (EMBC) presentation at J.P. Morgan 2026?
What is the stock symbol for Embecta presenting at the J.P. Morgan 2026 Healthcare Conference?
Where is the J.P. Morgan 2026 Healthcare Conference presentation by Embecta taking place?
Will the Embecta (EMBC) presentation at J.P. Morgan 2026 be available after the event?
